UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 10.

Combes, J D; Clifford, G M; Egger, M; Cavassini, M; Hirsch, H; Hauser, C; Calmy, A; Schmid, P; Bernasconi, E; Gunthard, H F; Franceschi, S; Waterboer, T; Scherrer, A U (2016). Human papillomavirus antibody response following highly active antiretroviral therapy initiation among men who have sex with men. AIDS, 31(4):561-569.

Clifford, G M; Lise, M; Franceschi, S; Egger, M; Bouchardy, C; Korol, D; Levi, F; Ess, S; Jundt, G; Wandeler, G; Fehr, J; Schmid, P; Battegay, M; Bernasconi, E; Cavassini, M; Calmy, A; Keiser, O; Schöni-Affolter, F (2012). Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection. British Journal of Cancer, 106(3):447-452.

Franceschi, S; Lise, M; Clifford, G M; Rickenbach, M; Levi, F; Maspoli, M; Bouchardy, C; Dehler, S; Jundt, G; Ess, S; Bordoni, A; Konzelmann, I; Frick, H; Dal Maso, L; Elzi, L; Furrer, H; Calmy, A; Cavassini, M; Ledergerber, B; Keiser, O; Swiss HIV Cohort Study (2010). Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. British Journal of Cancer, 103(3):416-422.

Sullivan, S G; Hirsch, H H; Franceschi, S; Steffen, I; Amari, E B E; Mueller, N J; Magkouras, I; Biggar, R J; Rickenbach, M; Clifford, G M (2010). Kaposi sarcoma herpes virus antibody response and viremia following highly active antiretroviral therapy in the Swiss HIV Cohort study. AIDS, 24(14):2245-2252.

Clifford, G M; Rickenbach, M; Lise, M; Dal Maso, L; Battegay, M; Bohlius, J; Boffi El Amari, E; Karrer, Urs; Jundt, G; Bordoni, A; Ess, S; Franceschi, S (2009). Hodgkin lymphoma in the Swiss HIV Cohort Study. Blood, 113(23):5737-5742.

Clifford, G M; Rickenbach, M; Polesel, J; Dal Maso, L; Steffen, I; Ledergerber, B; Rauch, A; Probst-Hensch, N M; Bouchardy, C; Levi, F; Franceschi, S (2008). Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma. AIDS, 22(16):2135-2141.

Franceschi, S; Maso, L D; Rickenbach, M; Polesel, J; Hirschel, B; Cavassini, M; Bordoni, A; Elzi, L; Ess, S; Jundt, G; Mueller, N; Clifford, G M; Swiss HIV Cohort Study (2008). Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. British Journal of Cancer, 99(5):800-804.

Polesel, J; Clifford, G M; Rickenbach, M; Dal Maso, L; Battegay, M; Bouchardy, C; Furrer, H; Hasse, B; Levi, F; Probst-Hensch, N M; Schmid, P; Franceschi, S (2008). Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. AIDS, 22(2):301-306.

Franceschi, S; Polesel, J; Rickenbach, M; Dal Maso, L; Probst-Hensch, N M; Fux, C; Cavassini, M; Hasse, B; Kofler, A; Ledergerber, B; Erb, P; Clifford, G M (2006). Hepatitis C virus and non-Hodgkin's lymphoma: Findings from the Swiss HIV Cohort Study. British Journal of Cancer, 95(11):1598-1602.

Clifford, G M; Polesel, J; Rickenbach, M; Dal Maso, L; Keiser, O; Kofler, A; Rapiti, E; Levi, F; Jundt, G; Fisch, T; Bordoni, A; De Weck, D; Franceschi, S (2005). Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. Journal of the National Cancer Institute, 97(6):425-432.

This list was generated on Mon Jul 24 04:54:11 2017 CEST.